OrbiMed’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-772,584
| Closed | -$1.29M | – | 127 |
|
|
2023
Q3 | $1.29M | Hold |
772,584
| – | – | 0.03% | 111 |
|
|
2023
Q2 | $1.85M | Sell |
772,584
-20,974
| -3% | -$50.1K | 0.03% | 113 |
|
|
2023
Q1 | $2.48M | Sell |
793,558
-37,083
| -4% | -$116K | 0.05% | 106 |
|
|
2022
Q4 | $2.23M | Hold |
830,641
| – | – | 0.04% | 101 |
|
|
2022
Q3 | $2.46K | Hold |
830,641
| – | – | 0.05% | 116 |
|
|
2022
Q2 | $2.43K | Hold |
830,641
| – | – | 0.04% | 123 |
|
|
2022
Q1 | $4.25M | Hold |
830,641
| – | – | 0.07% | 123 |
|
|
2021
Q4 | $5.61M | Buy |
830,641
+380,641
| +85% | +$2.57M | 0.07% | 131 |
|
|
2021
Q3 | $3.11M | Hold |
450,000
| – | – | 0.03% | 162 |
|
|
2021
Q2 | $4.38M | Hold |
450,000
| – | – | 0.04% | 148 |
|
|
2021
Q1 | $7.08M | Hold |
450,000
| – | – | 0.07% | 131 |
|
|
2020
Q4 | $10.9M | Hold |
450,000
| – | – | 0.1% | 121 |
|
|
2020
Q3 | $7.57M | Buy |
+450,000
| New | +$7.57M | 0.1% | 114 |
|